Article
Consortium analysis of 7 candidate SNPs for ovarian cancer.
International journal of cancer - 15 Jul 2008
Ramus Susan J, Vierkant Robert A, Johnatty Sharon E, Pike Malcolm C, Van Den Berg David J, Wu Anna H, Pearce Celeste Leigh, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, DiCioccio Richard A, McGuire Valerie, Whittemore Alice S, Song Honglin, Easton Douglas F, Pharoah Paul D P, Garcia-Closas Montserrat, Chanock Stephen, Lissowska Jolanta, Brinton Louise, Terry Kathryn L, Cramer Daniel W, Tworoger Shelley S, Hankinson Susan E, Berchuck Andrew, Moorman Patricia G, Schildkraut Joellen M, Cunningham Julie M, Liebow Mark, Kjaer Susanne Krüger, Hogdall Estrid, Hogdall Claus, Blaakaer Jan, Ness Roberta B, Moysich Kirsten B, Edwards Robert P, Carney Michael E, Lurie Galina, Goodman Marc T, Wang-Gohrke Shan, Kropp Silke, Chang-Claude Jenny, Webb Penelope M, Chen Xiaoqing, Beesley Jonathan, Chenevix-Trench Georgia, Goode Ellen L
Abstract excerpt
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs), for which there is evidence from previous studies of an association with variation in ovarian cancer or breast cancer risks. The SNPs selected for analysis were F31I (rs2273535) in AURKA, N372H (rs144848) in BRCA2, rs2854344 in intron 17 of RB1, 5' flanking CDKN2A, in the 3' UTR of SRD5A2,...